Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays the completed gantenerumab study record for prodromal Alzheimer’s disease, including its open-label extension, outcome measures, participant criteria, and study documents.
    Difference
    100%
    Check dated 2026-11-08T06:21:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:23:15.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice appears above the study page announcing NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:34:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the 403 error page otherwise remains unchanged.
    Difference
    0.2%
    Check dated 2026-10-18T05:11:35.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T06:54:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, replaced by a minimal error view with a Home link.
    Difference
    18%
    Check dated 2026-09-20T03:47:28.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.